{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T07:50:18Z","timestamp":1692690618803},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mod Rheumatol"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s10165-011-0507-7","type":"journal-article","created":{"date-parts":[[2011,8,17]],"date-time":"2011-08-17T14:05:26Z","timestamp":1313589926000},"page":"463-466","source":"Crossref","is-referenced-by-count":1,"title":["Rituximab as a new therapeutic option in granulomatosis with polyangiitis: a report of two cases"],"prefix":"10.1093","volume":"22","author":[{"given":"Ediz","family":"Dalkilic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nihan","family":"Alkis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevil","family":"Kamali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,8,17]]},"reference":[{"key":"507_CR1","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","volume":"116","author":"GS Hoffman","year":"1992","unstructured":"Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992;116:488\u201398.","journal-title":"Ann Intern Med"},{"key":"507_CR2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.amjmed.2004.02.030","volume":"117","author":"P Seo","year":"2004","unstructured":"Seo P, Stone JH. The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med. 2004;117:39\u201350.","journal-title":"Am J Med"},{"key":"507_CR3","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2165\/00003495-200363080-00005","volume":"63","author":"GL Plosker","year":"2003","unstructured":"Plosker GL, Figgitt DP. Rituximab: a review of its use in non-Hodgkin\u2019s lymphoma and chronic lymphocytic leukaemia. Drugs. 2003;63:803\u201343.","journal-title":"Drugs"},{"key":"507_CR4","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1002\/art.22025","volume":"54","author":"SB Cohen","year":"2006","unstructured":"Cohen SB, Emery P, Greenwald MW, Dougados M, Furie RA, Genovese MC, et al. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum. 2006;54:2793\u2013806.","journal-title":"Arthritis Rheum"},{"key":"507_CR5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJM197908023010503","volume":"301","author":"AS Fauci","year":"1979","unstructured":"Fauci AS, Katz P, Haynes BF, Wolff SM. Cyclophosphamide therapy of severe systemic necrotizing vasculitis. N Engl J Med. 1979;301:235\u20138.","journal-title":"N Engl J Med"},{"key":"507_CR6","first-page":"927","volume":"8","author":"SA Antoniu","year":"2007","unstructured":"Antoniu SA. Treatment options for refractory Wegener\u2019s granulomatosis: a role for rituximab? Curr Opin Investig Drugs. 2007;8:927\u201332.","journal-title":"Curr Opin Investig Drugs"},{"key":"507_CR7","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/1529-0131(200008)43:8<1836::AID-ANR20>3.0.CO;2-R","volume":"43","author":"CA Langford","year":"2000","unstructured":"Langford CA, Talar-Williams C, Sneller MC. Use of methotrexate and glucocorticoids in the treatment of Wegener\u2019s granulomatosis. Long-term renal outcome in patients with glomerulonephritis. Arthritis Rheum. 2000;43:1836\u201340.","journal-title":"Arthritis Rheum"},{"key":"507_CR8","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","volume":"52","author":"K Groot De","year":"2005","unstructured":"De Groot K, Rasmussen N, Bacon PA, Tervaert JW, Feighery C, Gregorini G, et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2005;52:2461\u20139.","journal-title":"Arthritis Rheum"},{"key":"507_CR9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12016-007-8026-1","volume":"34","author":"A Aouba","year":"2008","unstructured":"Aouba A, Pagnoux C, Bienvenu B, Mahr A, Guillevin L. Analysis of Wegener\u2019s granulomatosis responses to rituximab: current evidence and therapeutic prospects. Clin Rev Allergy Immunol. 2008;34:65\u201373.","journal-title":"Clin Rev Allergy Immunol"},{"key":"507_CR10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1749-4486.2009.01968.x","volume":"34","author":"M Martinez Del Pero","year":"2009","unstructured":"Martinez Del Pero M, Chaudhry A, Jones RB, Sivasothy P, Jani P, Jayne D. B-cell depletion with rituximab for refractory head and neck Wegener\u2019s granulomatosis: a cohort study. Clin Otolaryngol. 2009;34:328\u201335.","journal-title":"Clin Otolaryngol"},{"key":"507_CR11","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/art.24454","volume":"60","author":"SR Taylor","year":"2009","unstructured":"Taylor SR, Salama AD, Joshi L, Pusey CD, Lightman SL. Rituximab is effective in the treatment of refractory ophthalmic Wegener\u2019s granulomatosis. Arthritis Rheum. 2009;60:1540\u20137.","journal-title":"Arthritis Rheum"},{"key":"507_CR12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/RHU.0b013e31816b4487","volume":"14","author":"D Sanchez-Cano","year":"2008","unstructured":"Sanchez-Cano D, Callejas-Rubio JL, Ortego-Centeno N. Effect of rituximab on refractory Wegener granulomatosis with predominant granulomatous disease. J Clin Rheumatol. 2008;14:92\u20133.","journal-title":"J Clin Rheumatol"},{"key":"507_CR13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2174\/1874306400903010094","volume":"3","author":"J Oristrell","year":"2009","unstructured":"Oristrell J, Bejarano G, Jordana R, Monteagudo M, Mari B, Casanovas A, et al. Effectiveness of rituximab in severe Wegener\u2019s granulomatosis: report of two cases and review of the literature. Open Respir Med J. 2009;3:94\u20139.","journal-title":"Open Respir Med J"},{"key":"507_CR14","first-page":"2017","volume":"35","author":"P Seo","year":"2008","unstructured":"Seo P, Specks U, Keogh KA. Efficacy of rituximab in limited Wegener\u2019s granulomatosis with refractory granulomatous manifestations. J Rheumatol. 2008;35:2017\u201323.","journal-title":"J Rheumatol"},{"key":"507_CR15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/BOR.0b013e32831d28b3","volume":"21","author":"SA Chung","year":"2009","unstructured":"Chung SA, Seo P. Advances in the use of biologic agents for the treatment of systemic vasculitis. Curr Opin Rheumatol. 2009;21:3\u20139.","journal-title":"Curr Opin Rheumatol"},{"key":"507_CR16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"JH Stone","year":"2010","unstructured":"Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010;363:221\u201332.","journal-title":"N Engl J Med"},{"key":"507_CR17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","volume":"363","author":"RB Jones","year":"2010","unstructured":"Jones RB, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med. 2010;363:211\u201320.","journal-title":"N Engl J Med"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10165-011-0507-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T16:25:24Z","timestamp":1646843124000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10165-011-0507-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,17]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["507"],"URL":"https:\/\/doi.org\/10.1007\/s10165-011-0507-7","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,17]]}}}